Evidence map›Paper›PMID 35311642›Full record

ArticleeLife2022

Nucleoporin107 mediates female sexual differentiation via Dsx.

Tikva Shore, Tgst Levi, Rachel Kalifa, Amatzia Dreifuss, Dina Rekler, Ariella Weinberg-Shukron, Yuval Nevo, Tzofia Bialistoky, Victoria Moyal, Merav Yaffa Gold and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. TransgenicPharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Tikva Shore *Department of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.ORCID 0000-0002-7140-0226
Tgst Levi *Department of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.ORCID 0000-0001-9221-1873
Rachel KalifaDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.
Amatzia DreifussDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.
Dina ReklerDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.
Ariella Weinberg-ShukronMedical Genetics Institute, Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel.
Yuval NevoBioinformatics Unit of the I-CORE Computation Center, The Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Tzofia BialistokyDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.
Victoria MoyalDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.
Merav Yaffa GoldDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.ORCID 0000-0002-9978-2262
Shira LeebhoffDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.
David ZangenDivision of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Girish DeshpandeDepartment of Molecular Biology, Princeton University, Princeton, United States.ORCID 0000-0002-5200-7090
Offer GerlitzDepartment of Developmental Biology and Cancer Research, Institute of Medical Research Israel-Canada, The Hebrew University- Faculty of Medicine, Jerusalem, Israel.ORCID 0000-0002-1574-2088
Hebrew University of Jerusalem · ILHadassah Medical Center · ILPrinceton University · USShaare Zedek Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently identified a missense mutation in Nucleoporin107 (Nup107; D447N) underlying XX-ovarian-dysgenesis, a rare disorder characterized by underdeveloped and dysfunctional ovaries. Modeling of the human mutation in

Indexed as

AquaporinsDrosophila ProteinsAnimalsDNA-Binding ProteinsDrosophilaDrosophila melanogasterFemaleSex DifferentiationAquaporinsDNA-Binding ProteinsDrosophila ProteinsDSX protein, DrosophilaNup107 protein, Drosophiladevelopmental biologyD. melanogasterDpp pathwayNucleoporin107ovarian developmentsex differentiation

Identifiers

PMID35311642
PMCPMC8975549
OpenAlexW4220817989

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.